All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

First Macedonian child with tyrosinemia type 1 successfully treated with nitisinone and report of a novel mutation in the FAH gene

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F17%3A10369684" target="_blank" >RIV/00216208:11110/17:10369684 - isvavai.cz</a>

  • Alternative codes found

    RIV/00064165:_____/17:10369684

  • Result on the web

    <a href="http://dx.doi.org/10.2298/SARH161013084K" target="_blank" >http://dx.doi.org/10.2298/SARH161013084K</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.2298/SARH161013084K" target="_blank" >10.2298/SARH161013084K</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    First Macedonian child with tyrosinemia type 1 successfully treated with nitisinone and report of a novel mutation in the FAH gene

  • Original language description

    Introduction Hereditary tyrosinemia type 1 (HT1) is a severe hereditary metabolic disorder of tyrosine metabolism due to fumarylacetoacetate hydrolase (FAH) deficiency and accumulation of toxic products in tissues. More than 80 mutations in the FAH gene are presently reported on the Human Genome Mutation Database. To date, no molecular genetic defects of HT1 in Macedonia have been described. Case outline A female infant two and a half months old presented with failure to thrive, anemia, edemas, and severe coagulation disturbances. The diagnosis of HT1 was based on high levels of serum alpha-fetoprotein, increased serum tyrosine, and positive succinylacetone in urine. Nitisinone treatment with tyrosine-restriction diet was immediately introduced. The patient, currently aged five years, has normal growth, psychomotor development, and no focal lesions on abdominal MRI. A screening of the FAH gene revealed two heterozygous mutations - c.[1A&gt;G];[784T&gt;A]. The mutation c.784T&gt;A is a novel one (p.Trp262Arg), and was predicted to be the cause of the disease by an in silico analysis. Conclusion To date, this case is the first and only child with HT1 successfully treated with nitisinone in our country. Also, this is the first report of an HT1 patient caused by the c.784T&gt;A mutation.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    10600 - Biological sciences

Result continuities

  • Project

  • Continuities

    V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Others

  • Publication year

    2017

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Srpski Arhiv Za Celokupno Lekarstvo

  • ISSN

    0370-8179

  • e-ISSN

  • Volume of the periodical

    145

  • Issue of the periodical within the volume

    9-10

  • Country of publishing house

    RS - THE REPUBLIC OF SERBIA

  • Number of pages

    4

  • Pages from-to

    530-533

  • UT code for WoS article

    000423469500017

  • EID of the result in the Scopus database

    2-s2.0-85038360441